Matches in SemOpenAlex for { <https://semopenalex.org/work/W2532017670> ?p ?o ?g. }
- W2532017670 endingPage "1640" @default.
- W2532017670 startingPage "1635" @default.
- W2532017670 abstract "Combination studies of neurokinin 1 (NK1) receptor antagonists and serotonin-selective reuptake inhibitors (SSRIs) have shown promise in preclinical models of depression. Such a combination may offer important advantages over the current standard of care. Herein we describe the discovery and optimization of an indazole-based chemotype to provide a series of potent dual NK1 receptor antagonists/serotonin transporter (SERT) inhibitors to overcome issues of ion channel blockade. This effort culminated in the identification of compound 9, an analogue that demonstrated favorable oral bioavailability, excellent brain uptake, and robust in vivo efficacy in a validated depression model. Over the course of this work, a novel heterocycle-directed asymmetric hydrogenation was developed to facilitate installation of the key stereogenic center." @default.
- W2532017670 created "2016-10-28" @default.
- W2532017670 creator A5010145000 @default.
- W2532017670 creator A5012165450 @default.
- W2532017670 creator A5013435178 @default.
- W2532017670 creator A5031044594 @default.
- W2532017670 creator A5034055850 @default.
- W2532017670 creator A5035757280 @default.
- W2532017670 creator A5035901345 @default.
- W2532017670 creator A5036199580 @default.
- W2532017670 creator A5037690185 @default.
- W2532017670 creator A5038254883 @default.
- W2532017670 creator A5041084487 @default.
- W2532017670 creator A5041985756 @default.
- W2532017670 creator A5053427669 @default.
- W2532017670 creator A5058102521 @default.
- W2532017670 creator A5060087004 @default.
- W2532017670 creator A5062984211 @default.
- W2532017670 creator A5070377627 @default.
- W2532017670 creator A5070894857 @default.
- W2532017670 creator A5079436433 @default.
- W2532017670 creator A5081649221 @default.
- W2532017670 creator A5082703411 @default.
- W2532017670 creator A5083827325 @default.
- W2532017670 creator A5089077528 @default.
- W2532017670 creator A5091458811 @default.
- W2532017670 date "2016-10-18" @default.
- W2532017670 modified "2023-09-27" @default.
- W2532017670 title "Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression" @default.
- W2532017670 cites W1508200337 @default.
- W2532017670 cites W1972504730 @default.
- W2532017670 cites W1979617003 @default.
- W2532017670 cites W1992562625 @default.
- W2532017670 cites W2008661553 @default.
- W2532017670 cites W2016560535 @default.
- W2532017670 cites W2018285323 @default.
- W2532017670 cites W2020802357 @default.
- W2532017670 cites W2024053543 @default.
- W2532017670 cites W2025534441 @default.
- W2532017670 cites W2028733293 @default.
- W2532017670 cites W2028977103 @default.
- W2532017670 cites W2030926855 @default.
- W2532017670 cites W2033745488 @default.
- W2532017670 cites W2052714177 @default.
- W2532017670 cites W2053472601 @default.
- W2532017670 cites W2056421884 @default.
- W2532017670 cites W2062458432 @default.
- W2532017670 cites W2062815987 @default.
- W2532017670 cites W2064342700 @default.
- W2532017670 cites W2065463514 @default.
- W2532017670 cites W2073233024 @default.
- W2532017670 cites W2089299823 @default.
- W2532017670 cites W2106623141 @default.
- W2532017670 cites W2107125549 @default.
- W2532017670 cites W2111439580 @default.
- W2532017670 cites W2118659222 @default.
- W2532017670 cites W2140660757 @default.
- W2532017670 cites W2143608139 @default.
- W2532017670 cites W2149402043 @default.
- W2532017670 cites W2159853732 @default.
- W2532017670 cites W578782044 @default.
- W2532017670 doi "https://doi.org/10.1021/acschemneuro.6b00337" @default.
- W2532017670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27744678" @default.
- W2532017670 hasPublicationYear "2016" @default.
- W2532017670 type Work @default.
- W2532017670 sameAs 2532017670 @default.
- W2532017670 citedByCount "4" @default.
- W2532017670 countsByYear W25320176702018 @default.
- W2532017670 countsByYear W25320176702020 @default.
- W2532017670 countsByYear W25320176702021 @default.
- W2532017670 countsByYear W25320176702022 @default.
- W2532017670 crossrefType "journal-article" @default.
- W2532017670 hasAuthorship W2532017670A5010145000 @default.
- W2532017670 hasAuthorship W2532017670A5012165450 @default.
- W2532017670 hasAuthorship W2532017670A5013435178 @default.
- W2532017670 hasAuthorship W2532017670A5031044594 @default.
- W2532017670 hasAuthorship W2532017670A5034055850 @default.
- W2532017670 hasAuthorship W2532017670A5035757280 @default.
- W2532017670 hasAuthorship W2532017670A5035901345 @default.
- W2532017670 hasAuthorship W2532017670A5036199580 @default.
- W2532017670 hasAuthorship W2532017670A5037690185 @default.
- W2532017670 hasAuthorship W2532017670A5038254883 @default.
- W2532017670 hasAuthorship W2532017670A5041084487 @default.
- W2532017670 hasAuthorship W2532017670A5041985756 @default.
- W2532017670 hasAuthorship W2532017670A5053427669 @default.
- W2532017670 hasAuthorship W2532017670A5058102521 @default.
- W2532017670 hasAuthorship W2532017670A5060087004 @default.
- W2532017670 hasAuthorship W2532017670A5062984211 @default.
- W2532017670 hasAuthorship W2532017670A5070377627 @default.
- W2532017670 hasAuthorship W2532017670A5070894857 @default.
- W2532017670 hasAuthorship W2532017670A5079436433 @default.
- W2532017670 hasAuthorship W2532017670A5081649221 @default.
- W2532017670 hasAuthorship W2532017670A5082703411 @default.
- W2532017670 hasAuthorship W2532017670A5083827325 @default.
- W2532017670 hasAuthorship W2532017670A5089077528 @default.
- W2532017670 hasAuthorship W2532017670A5091458811 @default.
- W2532017670 hasConcept C118303440 @default.
- W2532017670 hasConcept C126322002 @default.